Summary: Researchers have discovered that psilocybin, a psychedelic compound in magic mushrooms, increases optimism and motivation in rats, suggesting potential therapeutic benefits for treating depression. Using computational modeling, scientists observed…
Category: Psychology
Gene Activity in Depression Linked to Immune System and Inflammation
Summary: A new study reveals that inflammation and immune system activation are closely linked to major depressive disorder (MDD), particularly in those resistant to standard antidepressants. Researchers analyzed gene expression…
Targeting Liver X Receptor Beta for Depression Treatment
Summary: A recent review highlights the potential of liver X receptor beta (LXRβ) as a target for treating depression and anxiety. Known for regulating cholesterol, LXRβ is emerging as a…
AI Admissions Essays Align with Privileged Male Writing Patterns
Summary: Researchers analyzed AI-generated and human-written college admissions essays, finding that AI-generated essays resemble those written by male students from privileged backgrounds. AI essays tended to use longer words and…
Psychedelics Reduce Anxiety Without Hallucinations
Summary: New research has pinpointed the specific brain region and neuron type responsible for reducing anxiety using the psychedelic drug DOI, without triggering hallucinations. The study revealed that DOI targets…
Reduced Brain Response to Visual Cues Linked to Psychosis in Parkinson’s
Summary: People with Parkinson’s disease (PD) who experience visual hallucinations have reduced brain responses to unexpected visual changes, a marker known as visual mismatch negativity (vMMN). Using EEG, researchers compared…
AI Detects Depression Through Eyes and Facial Cues
Summary: Researchers are developing AI-driven smartphone applications to detect signs of depression non-invasively. One system, PupilSense, monitors pupillary reflexes to identify potential depressive episodes with 76% accuracy. Another tool, FacePsy,…
